Comparative Efficacy of Antihypertensive Drugs for Primary Stroke Prevention–A Network Meta-Analysis of Randomized Controlled Trials
Lumina : Indonesian Journal of Neurology · 2025
DOI: 10.19166/lijn.v1i2.10286 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Lumina : Indonesian Journal of Neurology, 2025. Verfasst von Dessy Natalia und 2 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Hypertension is a major modifiable risk factor for stroke, making antihypertensive therapy essential for primary stroke prevention. However, the comparative efficacy of different antihypertensive drug classes remains uncertain. This study aims to evaluate the comparative efficacy of various antihypertensive drug classes in reducing the risk of stroke in patients with hypertension through a network meta-analysis of randomized controlled trials (RCTs).
Methods
A search was conducted using various online databases, including PubMed, Google Scholar, Scopus, and ScienceDirect, to identify RCTs which were written in English and published before January 2025. A network meta-analysis was performed to compare the effectiveness of different drug classes, including angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), beta-blockers, and diuretics in stroke primary prevention. Independently, two reviewers (D.N. and L.D.P.), extracted the data and assess the quality of studies using Cochrane RoB 2.0.
Results
This analysis included 43 RCTs involving 255299 participants with hypertension. Among the evaluated drug classes, non-dihydropyridine CCB demonstrated the highest efficacy in stroke prevention (RR 0.61; 95%CI 0.48 – 0.77), followed by dihydropyridine CCB (RR 0.62; 95%CI 0.54 – 0.72). Most of the studies had decent quality assessment with moderate heterogeneity across them with I2 = 39%. Egger’s test showed nonsignificant results (p= 0.16), suggesting the absence of publication bias in the included trials.
Conclusion
This meta-analysis showed that calcium channel blocker emerges as the most effective option for reducing stroke risk, but considerations of adverse effects and individual patient profiles remain critical in treatment selection.
Zitieren
APA
Natalia, D., Pradipta, L. D., & Alamsyaputra, A. (2025). Comparative Efficacy of Antihypertensive Drugs for Primary Stroke Prevention–A Network Meta-Analysis of Randomized Controlled Trials. Lumina : Indonesian Journal of Neurology. https://doi.org/10.19166/lijn.v1i2.10286
Vancouver
Natalia D, Pradipta LD, Alamsyaputra A. Comparative Efficacy of Antihypertensive Drugs for Primary Stroke Prevention–A Network Meta-Analysis of Randomized Controlled Trials. Lumina : Indonesian Journal of Neurology. 2025. doi:10.19166/lijn.v1i2.10286
BibTeX
@article{Natalia2025,
author = {Natalia, Dessy and Pradipta, Leo Deddy and Alamsyaputra, Adwin},
title = {Comparative Efficacy of Antihypertensive Drugs for Primary Stroke Prevention–A Network Meta-Analysis of Randomized Controlled Trials},
journal = {Lumina : Indonesian Journal of Neurology},
year = {2025},
doi = {10.19166/lijn.v1i2.10286}
}
EUVIMED